This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
TUESDAY, March 26, 2024 -- Chemicals found in common household products might damage the brain's wiring, a new study warns. These chemicals -- found in disinfectants, cleaners, hair products, furniture and textiles -- could be linked to.
Ludwig van Beethoven, one of the most celebrated musicians in human history, has a rather low genetic predisposition for beat synchronization, according to a new study.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Astronomers have concluded that an obscure class of galaxies known as Compact Symmetric Objects, or CSOs, are not young as previously thought but rather lead relatively short lives.
Merck is couting on Winrevair, which it acquired by buying Acceleron Pharma, to help soften the blow when Keytruda loses patent protection later this decade.
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Merck is couting on Winrevair, which it acquired by buying Acceleron Pharma, to help soften the blow when Keytruda loses patent protection later this decade.
TUESDAY, MARCH 26, 2024 -- Milk from dairy cows in Texas, Kansas and New Mexico has tested positive for the presence of bird flu, U.S. officials say.In a news release issued Monday, the U.S. Department of Agriculture (USDA) confirmed the virus.
Plastics are neither safe nor as inexpensive as they seem? A Strategy to Attack Aggressive Brain Cancer. Is LSD providing relief for Anxiety? And more.
TUESDAY, March 26, 2024 — New research offers an easy prescription to get people to roll up their sleeves for a flu shot.Just ask them to. And then reinforce the invitation with a little video and print encouragement."Our study adds to the.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
TUESDAY, March 26, 2025 -- A protein that shuts down immune cells in the lungs could be key to a new treatment for asthma attacks, a new report says.The naturally occurring protein, called Piezo1, prevents a type of immune cell called type 2 innate.
High-power lasers are often used to modify polymer surfaces to make high-tech biomedical products, electronics and data storage components. Now researchers have discovered a light-responsive, inexpensive sulfur-derived polymer is receptive to low power, visible light lasers -- promising a more affordable and safer production method in nanotech, chemical science and patterning surfaces in biological applications.
TUESDAY, March 26, 2024 -- Six out of every 10 stroke survivors wind up struggling with depression later in their lives, a new study says.That compares to the 22% depression rate of the general population, results show.Further, 9 of 10.
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
TUESDAY, March 26, 2024 — Less than 9% of rural Americans who abuse both opioids and alcohol are prescribed medications to treat both disorders, new research reveals.Naltrexone treats both opioid use disorder and alcohol use disorder. Other drugs.
The biotech is trying to develop a Spinraza-like drug for the condition, a form of genetic epilepsy. Fresh data appear supportive of a high dose’s effectiveness.
TUESDAY, March 26, 2024 — Honey bees fly to flowers whenever the weather is right, and warmer autumns and winters are putting these crop pollinators at risk, researchers warn.Using climate and bee population models, a Washington State University.
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Can you tell us about your journey in the field of STEM and the challenges you encountered along the way? DGG: I started my journey in STEM as a strategic consultant with various global pharmaceutical groups, working to solve specific strategic questions and being fully focused on one critical topic for a short time. After 10 years of supporting other teams, I wanted to become a full-time member and focus on using my analytic skills on a specific story that I believed in.
TUESDAY, March 26, 2024 -- It’s hard for some folks who suffer illness-related urinary incontinence to judge whether they’ll be able to hold it until they get home, or if they should rush to a bathroom now.There might soon be a new app for.
While the antibodies present throughout our bodies carry out plenty of roles just the way they are, the research antibodies in your refrigerator often need a little help to be useful. Mainly because, well, antibodies are kind of hard to see. To solve this issue, researchers conjugate various labels to antibodies that produce detectable signals like light or color.
TUESDAY, March 26, 2024 -- The bright lights of the big city might seem exciting, but they could also raise a person’s risk of stroke, a new study suggests.Bright artificial lights that illuminate the night seem to affect blood flow to the brain.
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
There is controversy whether H 1 -histamine receptors increase or decrease contractility in the mammalian heart. Therefore, we have generated mice that overexpress the human H 1 -histamine receptor in the heart (H 1 -TG). We hypothesized that histamine would either increase or decrease force of contraction and beating rate compared to littermate wild type mice (WT).
The PPD clinical research business of Thermo Fisher Scientific conducts an annual survey of more than 150 leaders at pharmaceutical companies around the globe to assess trends in drug discovery and development, including preferences around outsourcing and functional service provider (FSP) utilization. The results of our most recent survey are now available in the 2024 FSP Trends Report , which explores utilization and growth projections, outlines the future of FSP strategies and models, and high
University of Wyoming researchers have gained further insight into how tardigrades survive extreme conditions and shown that proteins from the microscopic creatures expressed in human cells can slow down molecular processes.
A theory has only the alternative of being true or false. A model has a third possibility: it may be true, but irrelevant. With apologies to Manfred Eigen (1927 - 2019) I've just returned to Cheshire from the Caribbean and, to kick off blogging from 2024 I'll share a photo of the orchids at Berwick-on-Sea on the north coast of Trinidad. Encountering words like “truth” and “beauty” (here's a good example ) in the titles of scientific articles always sets off warning bells for me and I’ll kick off
Researchers have used advanced sequencing technology to determine how the mix of microbes present in patients with healthy eyes differs from the mix found in patients with dry eye. The new work could lead to improved treatments for various eye problems and for diseases affecting other parts of the body. Credit: Pallavi Sharma, Stephen F.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content